Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Stock
-
Total 13F shares
-
110,993,915
-
Share change
-
+4,333,453
-
Total reported value
-
$164,247,829
-
Put/Call ratio
-
6.9%
-
Price per share
-
$1.48
-
Number of holders
-
113
-
Value change
-
+$6,461,700
-
Number of buys
-
45
-
Number of sells
-
48
Institutional Holders of RIGEL PHARMACEUTICALS INC COM - Stock (RIGL) as of Q1 2024
As of 31 Mar 2024,
RIGEL PHARMACEUTICALS INC COM - Stock (RIGL) was held by
113 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
110,993,915 shares.
The largest 10 holders included
ARMISTICE CAPITAL, LLC, BlackRock Inc., MORGAN STANLEY, VANGUARD GROUP INC, Soleus Capital Management, L.P., ACADIAN ASSET MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, Nuveen Asset Management, LLC, and JACOBS LEVY EQUITY MANAGEMENT, INC.
This page lists
113
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.